Filer Snapshot

Ghost Tree Capital, LLC

CIK 0001595851. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

58

Latest filing

14 Nov 2024

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13F-HR for Q3 2024. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Open 13F portfolio Save page

Latest 13F portfolio

$293.22M

51 holdings for Q3 2024

Open portfolio

Largest parsed holding

Biohaven Ltd

$17.43M reported value

Open holding

13D/G large stake

—

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC Form 13F

13F-HR filed on 14 Nov 2024 for CIK 0001595851.

View source filing
Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal
Parsed SEC ownership signals

Parsed SEC ownership coverage

These bars compare filing-backed value available in each disclosure family. Read them as separate lenses, not as one combined ownership total.

13F portfolio$293.22M

Quarterly institutional holdings reported on Form 13F.

Latest reported 13F value

13F
$293.22M

Reported market value from the latest parsed Form 13F information table; this is not total assets under management.

Largest 13F holdings

13F
BIOHAVEN LTD SRPT NVO BPMC AXSM
+15 moreTARS CATX CGON ROIV PCVX VKTX SNDX JANX ASND CRNX SLNO TGTX RZLT PHAT MLTX

Largest symbols in the latest parsed Form 13F information table.

Largest 13F holdings

Largest symbols in the latest parsed Form 13F information table.

BIOHAVEN LTD SRPT NVO BPMC AXSM TARS CATX CGON
+12 moreROIV PCVX VKTX SNDX JANX ASND CRNX SLNO TGTX RZLT PHAT MLTX
How to read these SEC ownership signals
  • Read each filing family separately: 13F portfolios, 13D/G large stakes, and Forms 3/4/5 owner positions answer different SEC disclosure questions.
  • Open the linked research path when you need the filing, CIK, issuer, or CUSIP trail behind a value.
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
667 Madison Avenue, 5 Th Floor, Suite 12, New York, NY, 10065
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Incorporated in
DE
Fiscal year end
31 December

Filer intelligence

What SEC filings say about Ghost Tree Capital, LLC

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Open 13F portfolio Save filer

Quick read

  • Latest parsed 13F shows $293.22M across 51 reported holdings for Q3 2024.
  • Largest parsed 13F holding: BIOHAVEN LTD at $17.43M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio 51 rows

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

Open

Top parsed 13F holdings

Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.

Q3 2024 - 14 Nov 2024

Top 5 concentration

24%

Share of latest parsed 13F value represented by the visible holdings below.

Top 5 reported value

$70.6M

Compared with $293.22M total 13F value.

Top 5 net change

+$46.55M

Position-value change inside the visible top holdings only.

13F concentration map

A simple visual split of the latest parsed 13F portfolio.

Largest add: Biohaven Ltd ยท Largest trim: BHVN

Biohaven Ltd SRPT NVO BPMC AXSM Other holdings

SRPT

5.1%

Sarepta Therapeutics Inc

$14.99M

NVO

4.5%

Novo Nordisk A S

$13.1M

BPMC

4.4%

Blueprint Medicines Corp

$12.95M

AXSM

4.1%

Axsome Therapeutics Inc

$12.13M

Latest update

What changed recently for Ghost Tree Capital, LLC

New filing available

Latest 13F period: Q3 2024. Open the source-backed page to inspect the fresh filing or facts context.

Update date

14 Nov 2024

Page type

Filer profile

Latest period

Q3 2024

Institutional portfolio context was refreshed from a 13F filing filed on 14 Nov 2024.

Open filer profile Browse recent public updates

Benchmark Context

Benchmark context for this company

Ghost Tree Capital, LLC has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest 13F period: Q3 2024. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

SEC filing record

CIK 0001595851 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
58
First seen
14 Feb 2014
Latest filing
14 Nov 2024
Entity
Company

Observed form types

13F-HR 13F-HR/A

CIK-linked evidence first

Ghost Tree Capital, LLC SEC filings Ghost Tree Capital, LLC 13F portfolio Open SEC filing index

Latest Filings

Showing the latest 12 of 58 SEC filings for Ghost Tree Capital, LLC.

Open full filing history
13F-HR

13F-HR filing

Filing date
14 Nov 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Aug 2024
Reporting date
30 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
15 May 2024
Reporting date
31 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Feb 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Nov 2023
Reporting date
30 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Aug 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
15 May 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Feb 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
15 Aug 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
16 May 2022
Reporting date
31 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
16 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .